1. Yang, Xinyu, Li, Jiani, Fang, Yabo, Zhong, Tao P, Yu, Fuli. . Rho Guanine Nucleotide Exchange Factor ARHGEF17 Is a Risk Gene for Intracranial Aneurysms. In Circulation. Genomic and precision medicine, 11, e002099. doi:10.1161/CIRCGEN.117.002099. https://pubmed.ncbi.nlm.nih.gov/29997225/
2. Isokane, Mayumi, Walter, Thomas, Mahen, Robert, Peters, Jan-Michael, Ellenberg, Jan. 2016. ARHGEF17 is an essential spindle assembly checkpoint factor that targets Mps1 to kinetochores. In The Journal of cell biology, 212, 647-59. doi:10.1083/jcb.201408089. https://pubmed.ncbi.nlm.nih.gov/26953350/
3. Ravindran, Ethiraj, Ullah, Noor, Mani, Shyamala, Kaindl, Angela M, Siddiqi, Saima. 2022. Case report: Expanding the phenotype of ARHGEF17 mutations from increased intracranial aneurysm risk to a neurodevelopmental disease. In Frontiers in neurology, 13, 1017654. doi:10.3389/fneur.2022.1017654. https://pubmed.ncbi.nlm.nih.gov/36341116/
4. García-Jiménez, Irving, Cervantes-Villagrana, Rodolfo Daniel, Del-Río-Robles, Jorge Eduardo, Reyes-Cruz, Guadalupe, Vázquez-Prado, José. 2021. Gβγ mediates activation of Rho guanine nucleotide exchange factor ARHGEF17 that promotes metastatic lung cancer progression. In The Journal of biological chemistry, 298, 101440. doi:10.1016/j.jbc.2021.101440. https://pubmed.ncbi.nlm.nih.gov/34808208/
5. Bloethner, Sandra, Mould, Arne, Stark, Mitchell, Hayward, Nicholas K. . Identification of ARHGEF17, DENND2D, FGFR3, and RB1 mutations in melanoma by inhibition of nonsense-mediated mRNA decay. In Genes, chromosomes & cancer, 47, 1076-85. doi:10.1002/gcc.20598. https://pubmed.ncbi.nlm.nih.gov/18677770/
6. Xu, Liyan, Yang, Kaili, Zhu, Meng, Pang, Chenjiu, Ren, Shengwei. 2022. Trio-based exome sequencing broaden the genetic spectrum in keratoconus. In Experimental eye research, 226, 109342. doi:10.1016/j.exer.2022.109342. https://pubmed.ncbi.nlm.nih.gov/36502923/
7. Ganief, Tariq, Gqamana, Putuma, Garnett, Shaun, Soares, Nelson, Blackburn, Jonathan M. 2017. Quantitative proteomic analysis of HIV-1 Tat-induced dysregulation in SH-SY5Y neuroblastoma cells. In Proteomics, 17, . doi:10.1002/pmic.201600236. https://pubmed.ncbi.nlm.nih.gov/28101920/